Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Agilent Acquires Its Analytic Joint Venture

By Biotechdaily staff writers
Posted on 16 Feb 2006
Agilent Technologies Inc. More...
(Palo Alto, CA, USA), and Yokogawa Electric Corp. (Tokyo, Japan) have announced that their joint venture, Yokogawa Analytical Systems, became a wholly owned Agilent subsidiary on February 1, 2006.

Yokogawa Analytical Systems was founded as a joint venture by Agilent and Yokogawa Electric in 1992. The company designed and produced measurement and control and industrial automation systems, including inductively coupled plasma mass spectrometry (ICP/MS) systems, which are analytic systems used in gas chromatography for laboratory and other scientific applications. Agilent and Yokogawa noted that the joint venture achieved its original objectives.

Agilent decided that it is the right time for Yokogawa Analytical Systems to become a wholly owned subsidiary in order to expand the market presence for its products and services in Japan. By selling its stake in the joint venture, Yokogawa Electric will be able to dedicate additional resources to its core businesses. The firm is receiving approximately U.S.$106 million for the transaction, including $98 million from Agilent for its 49% share in the joint venture, and $7.5 million in dividends from Yokogawa Analytical Systems.

Yokogawa Electric was founded in 1915 and is engaged in research and innovation. Its core businesses are industrial automation and control, test and measurement, information systems, and industry support.

"Yokogawa and Agilent have had a very strong, cooperative relationship over the past 13 years,” said Ryuji Kanno, president, Yokogawa Analytical Systems. "This acquisition of Yokogawa's minority share is a positive step for both companies.”



Related Links:
Agilent
Yokogawa

New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: A saliva test can help predict future metabolic health concerns including diabetes and obesity (Photo courtesy of 123RF)

Saliva Test to Enable Early Detection of Diabetes and Obesity

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. However, conditions like insulin resistance and hyperinsulinemia may begin developing... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.